New weapon against tough lung cancer enters human testing
NCT ID NCT05990738
Summary
This early-stage study aims to find a safe dose of an experimental drug called BI 764532 when given with standard chemotherapy. It is for adults whose extensive-stage small cell lung cancer has worsened after initial platinum-based treatment. The drug is designed to help the body's own immune system recognize and attack the cancer cells.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CARCINOMA (SCLC) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
HOP Civil
Strasbourg, 67091, France
-
INS Curie
Paris, 75005, France
-
Institut Gustave Roussy
Villejuif, 94805, France
-
Leicester Royal Infirmary
Leicester, LE1 5WW, United Kingdom
-
Mayo Clinic - Florida
Jacksonville, Florida, 32224, United States
-
MedStar Georgetown University Hospital
Washington D.C., District of Columbia, 20007, United States
-
Polish Mother's Memorial Hospital - Research Institute
Lodz, 93-338, Poland
-
Thoraxklinik-Heidelberg gGmbH am Universitätsklinikum Heidelberg
Heidelberg, 69126, Germany
-
University of Miami
Miami, Florida, 33136, United States
-
Universitätsklinikum Carl Gustav Carus Dresden
Dresden, 01307, Germany
-
Universitätsklinikum Erlangen
Erlangen, 91054, Germany
-
Universitätsklinikum Würzburg AÖR
Würzburg, 97078, Germany
-
Universitätsmedizin der Johannes Gutenberg-Universität Mainz
Mainz, 55131, Germany
-
Virginia Commonwealth University
Richmond, Virginia, 23219, United States
Conditions
Explore the condition pages connected to this study.